Audio By Carbonatix
Some $3bn (£2.4bn) will be invested over the next 10 years to end vaccine dependency across the continent, the Africa Development Bank (AfDB) has pledged.
The plan includes a new pharmaceutical centre for research, development and manufacturing based in Rwanda's capital, Kigali.
It has been widely lauded as key towards ending Africa’s dependence on outside donations, as recently witnessed during the Covid-19 pandemic
AfDB says it will also help patent and license African-made medicines, and support governments to navigate the intellectual property rights to global vaccines and medicines.
It follows a recent World Trade Organisation announcement of a partial waiver on coronavirus vaccine patents, allowing select developing countries to produce the jabs.
AfDB says Africa currently imports more than 70% of all its medicines, spending about $14bn every year.
Latest Stories
-
Rule of law must prevail – Kwakye Ofosu defends gov’t position on OSP case
22 minutes -
Woman, 24, allegedly attacked during robbery attempt at Akatsi
40 minutes -
Dram–Deloitte trial raises cross-border, UK liability questions
52 minutes -
OSP’s future may depend on Constitutional Review – Felix Kwakye Ofosu
1 hour -
Mahama fully backs the OSP – Gov’t rejects secret plot claims
1 hour -
Study urges balanced expectations for agricultural innovations being developed in Ghana
2 hours -
Putin says Russia-China ties at unprecedented level, invites Xi to Russia
2 hours -
Woman dies after falling into uncovered New York City manhole
2 hours -
Trump to attend G7 summit in France, Axios reports
2 hours -
UK should set maximum working temperature rules, advisers say
2 hours -
UK loosens Russian oil sanctions as fuel prices rise
2 hours -
‘Ebola has tortured us’: Fear grips eastern DR Congo as deadly virus spreads
3 hours -
Lebanon says 19 killed in Israeli air strikes
3 hours -
Thailand cuts visa-free stay period for more than 90 countries including UK
3 hours -
Man who murdered teen TikTok star in Pakistan gets death sentence
3 hours